NCT04189133View on ClinicalTrials.gov

Rec-LH PD and Safety Profile in Hypogonadotropic Hypogonadism Men

PHASE2RecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

January 19, 2022

Primary Completion Date

January 18, 2025

Study Completion Date

January 18, 2026

Conditions
Acquired Hypogonadotropic Hypogonadism
Interventions
DRUG

Lutropin alfa

daily increasing dosages of lutropin alfa

DRUG

Human chorionic gonadotropin

human chorionic gonadotropin increasing administration

Trial Locations (5)

41126

RECRUITING

Unit of Endocrinology of Modena, Modena

Unknown

NOT_YET_RECRUITING

Fondazione IRCCS Ca ' Grande Ospedale Maggiore Policlinico, Milan

NOT_YET_RECRUITING

"Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Università degli Studi di Napoli Federico II", Naples

NOT_YET_RECRUITING

Department of Experimental Medicine, Section of Medical Pathophysiology, Food Science and Endocrinology, Sapienza - University of Rome, Rome

NOT_YET_RECRUITING

ivision of Endocrinology, Diabetes and Metabolism, Department of Medical Science, University of Turin, Turin

All Listed Sponsors
lead

Azienda Ospedaliero-Universitaria di Modena

OTHER